S-nitrosothiols in lung inflammation

Therapeutic Targets in Airway Inflammation

Volumn , Issue , 2003, Pages 123-142

  Marshall, Harvey E ^a   Que, Loretta G ^a   Stamler, Jonathan S ^a   Gaston, Benjamin ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942092311     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (117)

1. Stamler JS, et al. Nitric oxide circulates in mammalian plasma primarily as an Snitroso adduct of serum albumin. Proc Natl Acad Sci USA 1992; 89(16):7674-7677.
2. Gaston B, et al. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols inhuman airways. Proc Natl Acad Sci USA 1993; 90(23):10957-10961.
3. Lander HM, et al. A molecular redox switch on p21ras. Structural basis for the nitricoxide-p21ras interactions. J Biol Chem 1997; 272(7):4323-4326.
4. Xu L, et al. Activation of the cardiac calcium release channel (ryanodine receptor) bypoly-S-nitrosylation. Science 1998; 279(5348):234-237.
5. Lipton SA, et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993; 364(6438):626-632.
6. Mannick JB, et al. Fas-induced caspase denitrosylation. Science 1999; 284(5414):651-654.
7. Mannick JB, et al. S-Nitrosylation of mitochondrial caspases. J Cell Biol 2001; 154(6):1111-1116.
8. Marshall HE, Stamler JS. Inhibition of NF-kappa B by S-nitrosylation. Biochemistry2001; 10(6):1688-1693.
9. Stamler JS, et al. Blood flow regulation by S-nitrosohemoglobin in the physiologicaloxygen gradient. Science 1997; 276(5321):2034-2037.
10. Ignarro LJ, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiolsas active intermediates. J Pharmacol Exp Ther 1981; 218(3):739-749.
11. Creager MA, et al. ^-Acetylcysteine does not influence the activity of endothelium-derived relaxing factor in vivo. Hypertension 1997; 29(2):668-672.
12. Stamler JS, et al. S-Nitrosylation of proteins with nitric oxide: Synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 1992; 89(1):444-448.
13. Gaston B, et al. Relaxation of human bronchial smooth muscle by S-nitrosothiols invitro. J Pharmacol Exp Ther 1994; 268(2):978-984.
14. Fang FC. Perspective series: Host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997; 99(12):2818-2825.
15. Mayer B, et al. A new pathway of nitric oxide/cyclic GMP signaling involving S-nitrosoglutathione. J Biol Chem 1998; 273(6):3264-3270.
16. Hofmann H. Schmidt HH. Thiol dependence of nitric oxide synthase. Biochemistry1995; 34(41):13443-13452.
17. Schmidt HH, et al. No. NO from NO synthase. Proc Natl Acad Sci USA 1996; 93(25):14492-14497.
18. Gaston B, et al. The biology of nitrogen oxides in the airways. Am J Respir Crit CareMed 1994; 149(2 Pt 1):538-551.
19. +, NO, and NO~ donation by S-nitrosothiols: Implicationsfor regulation of physiological functions by S-nitrosylation and acceleration of disulfideformation. Arch Biochem Biophys 1995; 318(2):279-285.
20. Liu L, et al. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans.Nature 2001; 410(6827):490-494.
21. Jia L, et al. S-Nitrosohaemoglobin: A dynamic activity of blood involved in vascularcontrol. Nature 1996; 380(6571):221-226.
22. Kluge I, et al. S-Nitrosoglutathione in rat cerebellum: Identification and quantificationby liquid chromatography-mass spectrometry. J Neurochem 1997; 69(6):2599-2607.
23. Eu JP, et al. An apoptotic model for nitrosative stress. Biochemistry 2000; 39(5):1040-1047.
24. Salt TE, et al. Novel mode of nitric oxide neurotransmission mediated via S-nitroso-cysteinyl-glycine. Eur J Neurosci 2000; 12(11):3919-3925.
25. Gow AJ, et al. Basal and stimulated protein S-nitrosylation in multiple cell types andtissues. Proc Natl Acad Sci USA 2001.
26. Lorch SA, et al. Immunohistochemical localization of protein 3-nitrotyrosine and S-nitrosocysteine in a murine model of inhaled nitric oxide therapy. Pediatr Res 2000;47(6):798-805.
27. Hasuda T, et al. Improvement in exercise capacity with nitric oxide inhalation inpatients with precapillary pulmonary hypertension. Circulation 2000; 101(17):2066-2070.
28. Kinsella JP, et al. Inhaled nitric oxide in premature neonates with severe hypoxaemicrespiratory failure: A randomised controlled trial. Lancet 1999; 354(9184):1061 -1065.
29. Rossaint R, et al. Inhaled nitric oxide for the adult respiratory distress syndrome. NEngl J Med 1993; 328(6):399-405.
30. Marshall HE, Que, L, Stamler JS. Resistance of the respiratory epithelium to S-nitrosos-thiol-induced apoptosis. American Thoracic Society, 2001.
31. Asano K, et al. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci USA 1994; 91(21):10089-10093.
32. Dweik RA, et al. NO chemical events in the human airway during the immediateand late antigen-induced asthmatic response. Proc Natl Acad Sci USA 2001; 98(5):2622-2627.
33. Lilly CM, et al. Modulation of vasoactive intestinal peptide pulmonary relaxationby NO in tracheally superfused guinea pig lungs. Am J Physiol 1993; 265(4 Pt 1):L410-L415.
34. Thompson DC, Altiere RJ. Differential susceptibility of tracheal contraction to nonadrenergic noncholinergic relaxation. J Pharmacol Exp Ther 1998; 284(1):19-24.
35. Tyurin VA, et al. Elevated levels of S-nitrosoalbumin in preeclampsia plasma. CircRes 2001; 88(11):1210-1215.
36. McMahon TJ, Huang YC, Pawloski J, Stamler JS. Modulation of hypoxic pulmonaryvasoconstriction by erythrocytic nitric oxide (abstr). Circulation 2001; 17:228.
37. Day BJ, et al. Transduction of nitric oxide synthase activity from endothelium tovascular smooth muscle: Involvement of S-nitrosothiols. In Proceedings of the 4thInternational Meeting on the Biology of Nitric Oxide. Amelia Island, FL: Portlandpress, 1996.
38. Jaffrey SR, et al. Protein S-nitrosylation: A physiological signal for neuronal nitricoxide. Nature Cell Biol 2001; 3(2):193-197.
39. Goemen C, et al. A possible role of S-nitrosothiols at the nitrergic relaxations in themouse corpus cavernosum. Eur J Pharmacol 1998; 361(1):85-92.
40. Clancy RM, et al. Nitric oxide reacts with intracellular glutathione and activates thehexose monophosphate shunt in human neutrophils: Evidence for S-nitrosoglutathioneas a bioactive intermediary. Proc Natl Acad Sci USA 1994; 91(9):3680-3684.
41. Stamler JS, Singel, DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activatedforms. Science 1992; 258(5090):1898-1902.
42. Stamler JS. Redox signaling: Nitrosylation and related target interactions of nitric oxide.Cell 1994; 78(6):931-936.
43. Vanin AF, Malenkova, IV, Serezhenkov VA. Iron catalyzes both decomposition andsynthesis of S-nitrosothiols: Optical and electron paramagnetic resonance studies. NitricOxide 1997; 1(3):191-203.
44. Inoue K, et al. Nitrosothiol formation catalyzed by ceruloplasmin. Implication forcytoprotective mechanism in vivo. J Biol Chem 1999; 274(38):27069-27075.
45. Gow AJ, Buerk, DG, Ischiropoulos H. A novel reaction mechanism for the formationof S-nitrosothiol in vivo. J Biol Chem 1997; 272(5):2841-2845.
46. Hess DT, et al. S-Nitrosylation: Spectrum and specificity. Nat Cell Biol 2001; 3(2):E46-49.
47. Choi YB, et al. Molecular basis of NMDA receptor-coupled ion channel modulationby S-nitrosylation. Nat Neurosci 2000; 3(1):15-21.
48. Perez-Mato I, et al. Methionine adenosyltransferase S-nitrosylation is regulated by thebasic and acidic amino acids surrounding the target thiol. J Biol Chem 1999; 274(24):17075-17079.
49. Nijkamp FP, van der Linde, HJ, Folkerts G. Nitric oxide synthesis inhibitors induceairway hyperresponsiveness in the guinea pig in vivo and in vitro. Role of the epithelium. Am Rev Respir Dis 1993; 148(3):727-734.
50. Marshall HE, Stamler JS. NO waiting to exhale in asthma. Am J Respir Crit Care Med2000; 161(3 Pt 1):685-687.
51. Jansen A, et al. The relaxant properties in guinea pig airways of S-nitrosothiols. JPharmacol Exp Ther 1992; 261(1):154-160.
52. Bannenberg G, et al. Characterization of bronchodilator effects and fate of S-nitrosothiols in the isolated perfused and ventilated guinea pig lung. J Pharmacol Exp Ther1995; 272(3):1238-1245.
53. Dupuy PM, et al. Bronchodilator action of inhaled nitric oxide in guinea pigs. J ClinInvest 1992; 90(2):421-428.
54. Perkins WJ, et al. cGMP-independent mechanism of airway smooth muscle relaxationinduced by S-nitrosoglutathione. Am J Physiol 1998; 275(2 Pt 1):C468-474.
55. Hermle G, et al. Ventilation-perfusion mismatch after lung ischemia-reperfusion. Protective effect of nitric oxide. Am J Respir Crit Care Med 1999; 160(4):1179-1187.
56. 23-deficient mice. J Clin Invest 1999; 104(10):1421-1429.
57. McMahon TJ, Ignarro, LJ, Kadowitz PJ. Influence of Zaprinast on vascular tone andvasodilator responses in the cat pulmonary vascular bed. J Appl Physiol 1993; 74(4):1704-1711.
58. Emery CJ. Vasodilator action of the S-nitrosothiol, SNAP, in rat isolated perfusedlung. Physiol Res 1995; 44(1):19-24.
59. Guarin M, Dawson, CA, Nelin LD. The arterial site of action of nitric oxide in theneonatal pig lung determined by microfocal angiography. Lung 2001; 179(1):43-55.
60. Moya MP, et al. S-Nitrosothiol repletion by an inhaled gas regulates pulmonary function. Proc Natl Acad Sci USA 2001; 98(10):5792-5797.
61. Jain L, et al. Nitric oxide inhibits lung sodium transport through a cGMP-mediatedinhibition of epithelial cation channels. Am J Physiol Lung Cell Mol Physiol 1998;274(4):L475-484.
62. Duszyk M. Regulation of anion secretion by nitric oxide in human airway epithelialcells. Am J Physiol Lung Cell Mol Physiol 2001; 281(2):L450-457.
63. Li, D, et al. Regulation of giliary beat frequency by the nitric oxide-cyclic guanosinemonophosphate signaling pathway in but airway epithelial cells. Am J Respir CellMol Biol 2000; 23(2):175-181.
64. Kamosinska B, et al. Role of inducible nitric-oxide synthase in regulation of wholecell current in lung epithelial cells. J Pharmacol Exp Ther 2000; 295(2):500-505.
65. Kamosinska B et al., Nitric oxide activates chloride currents in human lung epithelialcells. Am J Physiol 1997; 272(6 Pt 1):L1098-1104.
66. Zaman K, et al. S-Nitrosoglutathione increases cystic fibrosis transmembrane regulatormaturation. Biochem Biophys Res Commun 2001; 284(1):65-70.
67. Andersson C, Gaston B, Roomans GM. S-Nitrosoglutathione induces functional AF508 CFTR in cultured airway epithelial cells. Biochem Biophys Res Commun 2002;297:552-556.
68. Grasemann HMD, et al. Decreased levels of nitrosothiols in the lower airways ofpatients with cystic fibrosis and normal pulmonary function. J Pediatrics 1999; 135(6):770-772.
69. Snyder A, McPherson ME, Hunt JF, Johnson M, Stamler JS, Gaston B. Acute effectsof aerosolized S-Nitrosoglutathione in cystic fibrosis. Am J Respir Crit Care Med2002; 165:922-926.
70. Li J, et al. Nitric oxide suppresses apoptosis via interrupting caspase activation andmitochondrial dysfunction in cultured hepatocytes. J Biol Chem 1999; 274(24):17325-17333.
71. Fortenberry JD, et al. S-Nitrosoglutathione inhibits TNF-alpha-induced NFkappaB activation in neutrophils. Inflamm Res 2001; 50(2):89-95.
72. Wenzel SE, et al. Evidence that severe asthma can be divided pathologically into twoinflammatory subtypes with distinct physiologic and clinical characteristics. Am JRespir Crit Care Med 1999; 160(3):1001-1008.
73. Gaston B, et al. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet 1998; 351(9112):1317-1319.
74. Hamad AM, Johnson SR, Knox AJ. Antiproliferative effects of NO and ANP in cultured human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 1999; 277(5):L910-918.
75. Rubin DB, et al. Non-protein thiols flux to S-nitrosothiols in endothelial cells: An LPSredox signal. Shock 2000; 14(2):200-207.
76. De Groote MA, et al. Genetic and redox determinants of nitric oxide cytotoxicity ina Salmonella typhimurium model. Proc Natl Acad Sci USA 1995; 92(14):6399-6403.
77. Gobert AP, et al. Murine macrophages use oxygen- and nitric oxide-dependent mechanisms to synthesize S-nitroso-albumin and to kill extracellular trypanosomes. InfectImmun 1998; 66(9):4068-4072.
78. Saura M, et al. An antiviral mechanism of nitric oxide: Inhibition of a viral protease.Immunity 1999; 10(1):21-28.
79. Hausladen A, et al. Nitrosative stress: Activation of the transcription factor OxyR. Cell1996; 86:719-729.
80. Spiecker M, et al. Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukoc Biol 1998; 63(6):732-739.
81. Bloomfield GL. M. D, et al. Pretreatment with inhaled nitric oxide inhibits neutrophilmigration and oxidative activity resulting in attenuated sepsis-induced acute lung injury. Crit Care Med 1997; 25(4):584-593.
82. Marshall HE, Merchant K, Stamler JS. Nitrosation and oxidation in the regulation ofgene expression. FASEB J 2000; 14:1-12.
83. Peng H.-B., Libby P, Liao JK. Induction and stabilization of I-kappa B alpha by nitricoxide mediates inhibition of NF-kappa B. J Biol Chem 1995; 270(23):14214-14219.
84. Shin WS, et al. Nitric oxide attenuates vascular smooth muscle cell activation byinterferon-[IMAGE]. J Biol Chem 1996; 271(19):11317-11324.
85. dela Torre A, et al. Endotoxin-mediated S-nitrosylation of p50 alters NF-kappa B-dependent gene transcription in ANA-1 murine macrophages. J Immunol 1999; 162(7):4101-4108.
86. Nikitovic D, Holmgren A, Spyrou G. Inhibition of AP-1 DNA binding by nitric oxideinvolving conserved cysteine residues in Jun and Fos. Biochem Biophys Res Commun1998; 242(1):109-112.
87. Palmer LA, Gaston B, Johns RA. Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: Redox-dependent effect of nitrogen oxides. Mol Pharmacol2000; 58(6):1197-1203.
88. Park JW. Attenuation of p47phox and p67phox membrane translocation as the inhibitory mechanism of S-nitrosothiol on the respiratory burst oxidase in human neutrophils.Biochem Biophys Res Commun 1996; 220(1):31-35.
89. Kim S, Ponka P. Effects of interferon-gamma and lipopolysaccharide on macrophageiron metabolism are mediated by nitric oxide-induced degradation of iron regulatoryprotein 2. J Biol Chem 2000; 275(9):6220-6226.
90. Butzer U, et al. Increased oxidative stress in the RAW 264.7 macrophage cell line ispartially mediated via the S-nitrosothiol-induced inhibition of glutathione reductase.FEBS Lett 1999; 445(2-3):274-278.
91. Moellering D, et al. The induction of GSH synthesis by nanomolar concentrations ofNO in endothelial cells: A role for [gamma]-glutamylcysteine synthetase and [gamma]-glutamyl transpeptidase. FEBS Lett 1999; 448(2-3):292-296.
92. Lipton AJ, et al. S-Nitrosothiols signal the ventilatory response to hypoxia. Nature2001; 413(6852):171-174.
93. Trujillo M, et al. Xanthine oxidase-mediated decomposition of S-nitrosothiols. J BiolChem 1998; 273(14):7828-7834.
94. Nikitovic D, Holmgren A. S-Nitrosoglutathione is cleaved by the thioredoxin systemwith liberation of glutathione and redox regulating nitric oxide. J Biol Chem 1996;271(32):19180-19185.
95. Hogg N, et al. S-Nitrosoglutathione as a substrate for gamma-glutamyl transpeptidase.Biochem J 1997; 23(Pt 2):477-481.
96. Hou Y, et al. Seleno compounds and glutathione peroxidase catalyzed decompositionof S-nitrosothiols. Biochem Biophys Res Commun 1996; 228(1):88-93.
97. Tracey WR, et al. Immunochemical detection of inducible NO synthase in human lung.Am J Physiol 1994; 66(6 Pt 1):L722-727.
98. Guo FH, et al. Continuous nitric oxide synthesis by inducible nitric oxide synthase innormal human airway epithelium in vivo. Proc Natl Acad Sci USA 1995; 92(17):7809-7813.
99. Nicholson S, et al. Inducible nitric oxide synthase in pulmonary alveolar macrophagesqfrom patients with tuberculosis. J Exp Med 1996; 183(5):2293-2302.
100. Redington AE, et al. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax 2001; 56(5):351 -357.
101. Corradi M, et al. Increased nitrosothiols in exhaled breath condensate in inflammatoryairway diseases. Am J Respir Crit Care Med 2001; 163(4):854-858.
102. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled airof asthmatics. Eur Respir J 1993; 6(9):1368-1370.
103. Kharitonov SA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet1994; 43(8890):133-135.
104. Massaro AF, et al. Expired nitric oxide levels during treatment of acute asthma. AmJ Respir Crit Care Med 1995; 152(2):800-803.
105. Hunt J, et al. Condensed expirate nitrite as a home marker for acute asthma. Lancet1995; 346(8984):1235-1236.
106. Hunt JF, et al. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 2000; 161(3 Pt 1):694-699.
107. Smith LJ, Houston, M, Anderson J. Increased levels of glutathione in bronchoalveolarlavage fluid from patients with asthma. Am Rev Respir Dis 1993; 147(6 Pt 1):1461-1464.
108. Marshall HE, Stamler JS. Exhaled nitric oxide (NO), NO synthase activity, and regulation of nuclear factor (NF)-kappaB. Am J Respir Cell Mol Biol 1999; 21(3):296-297.
109. Fang K, et al. S-Nitrosoglutathione breakdown prevents airway smooth muscle relaxation in the guinea pig. Am J Physiol Lung Cell Mol Physiol 2000; 279(4):L716-721.
110. Linnane SJ, et al. Total sputum nitrate plus nitrite is raised during acute pulmonaryinfection in cystic fibrosis. Am J Respir Crit Care Med 1998; 158(1):207-212.
111. Kelley TJ, Drumm ML. Inducible nitric oxide synthase expression is reduced in cysticfibrosis murine and human airway epithelial cells. J Clin Invest 1998; 102(6):1200-1207.
112. Meng QH, et al. Lack of inducible nitric oxide synthase in bronchial epithelium: Apossible mechanism of susceptibility to infection in cystic fibrosis. J Pathol 1998;184(3):323-331.
113. Grasemann H, et al. Airway nitric oxide levels in cystic fibrosis patients are relatedto a polymorphism in the neuronal nitric oxide synthase gene. Am J Respir Crit CareMed 2000; 162(6):2172-2176.
114. Grasemann H, et al. Decreased concentration of exhaled nitric oxide (NO) in patientswith cystic fibrosis. Pediatr Pulmonol 1997; 24(3):173-177.
115. Hausladen A, Gow AJ, Stamler JS. Nitrosative stress: Metabolic pathway involvingthe flavohemoglobin. Proc Natl Acad Sci USA 1998; 95(24):14100-14105.
116. Kim SO, et al. Anoxic function for the Escherichia coli flavohaemoglobin (Hmp):reversible binding of nitric oxide and reduction to nitrous oxide. FEBS Lett 1999;445(2-3):389-394.
117. Gardner PR, et al. Nitric oxide dioxygenase: An enzymic function for flavohemoglobin.Proc Natl Acad Sci USA 1998; 95(18):10378-10383.